Default

Advances in translational imaging are furthering the discovery and optimisation of tomorrow's therapeutics. Careful integration of existing imaging technologies can help to quantify the critical properties and effects of new medicines, meaning patient risk can be mitigated and benefi ts maximised.

With state-of-the-art statistical modeling and operational processes, we have the data access and tools to design and execute the most effective strategy for your clinical study.

The productivity rate of drug development continues to fall, with clinical trial efficiency a driving factor. Learn more about how adaptive clinical trials can improve both predictability and efficiency.

An interactive tool: Every stage of your product's development presents an opportunity to grow value.

Understand how research informed where the product may fit into the future landscape as well as how the proposed indications may restrict its use in certain markets and how it would affect the launch and market access.

67th Annual Meeting of the National Hemophilia Foundation, 2015

ACCP 2015 - For multiple decades, there was a presumption that women of child-bearing age should automatically be excluded from any clinical study.